HPV Vaccination Programs in LMICs from Asia & Western Pacific Regions Symposium – Report

This report summarizes the fourth CHIC symposium, held in Manila, Philippines (October 2–4, 2024), bringing together 95 participants from 17 countries across the Asia and Western Pacific regions. Participants included civil society organizations, Ministries of Health and Education, NGOs, NITAG members, EPI managers, and key global partners including WHO, UNICEF, Gavi, JSI, and PATH. The […]

HPV Vaccination Implementation Strategies: Service Delivery – Lessons Learned and Best Practices – Q&A Session

This Q&A session explored practical insights on HPV vaccination strategies from Malaysia, Singapore, and Myanmar. Singapore emphasized centralized funding for health promotion, driven by its aging population and preventive care focus. Malaysia described its procurement process, balancing cost efficiency with program consistency, and detailed engagement with religious authorities to enhance vaccine acceptance. Myanmar shared how […]

Regional HPV Vaccination Investments: Q&A Session

The Q&A addressed future HPV investments under Gavi 6.0, focusing on Health System Strengthening (HSS) funds, prioritization for HPV, and sustainability beyond 2025. Panelists clarified that current HPV‑specific opportunities should be leveraged now, as the next strategy (2026–2030) may shift toward more flexible health system approaches. The Gates Foundation highlighted ongoing work to identify and […]

Gavi Investments

The Gavi session outlined its 2022 “must‑win” priority to scale up HPV vaccination, aiming to immunize 86 million girls by 2025. It detailed support for both Gavi‑eligible and middle‑income countries, including vaccine grants, operational funding, health‑system strengthening, and pooled procurement mechanisms. The presentation highlighted rapid progress post‑COVID, new multi‑age cohort campaigns, and upcoming introductions in […]

Multi-sectorial Coordination and Partmerships: Q&A Session

The session’s Q&A highlighted strategies to overcome vaccine hesitancy and ensure equitable HPV vaccine access in Indonesia and Malaysia. Indonesia’s approach leverages religious leaders, local manufacturing, and cross-ministerial decrees to build trust and improve uptake in multiethnic communities. Malaysia emphasized civil society’s role in reaching marginalized groups, tackling myths, and using community leaders to counter […]

HPV vaccine cost and procurement: Q&A Session

The session’s discussion highlighted supply dynamics and market diversification for HPV vaccines, with UNICEF confirming five WHO-prequalified products currently available and several others in the pipeline, including a quadrivalent vaccine from SII. Participants raised questions on whether increased suppliers could reduce prices and how demand fluctuations after multi-age cohorts might affect costs. Indonesia and Lao […]

Policy, Schedule and Vaccine Product Choice: Q&A Session

The Q&A session highlighted critical considerations for transitioning to single-dose HPV vaccination, including evidence needs for NITAG decision-making, updates on ongoing trials like HANDS, and the unique immunological advantages of virus-like particle vaccines. Participants raised concerns about vaccine efficacy in older adolescents, genotype distribution differences (e.g., HPV 52 prevalence), and implications for vaccine selection. Discussions […]

Regional overview: Cervical cancer epidemiology and HPV vaccination progress; Q&A Session

The Q&A session highlighted key implementation challenges and strategies for HPV vaccination in the Western Pacific and Southeast Asia regions. Questions focused on vaccine efficacy in older cohorts, strategies for multi-age campaigns, and the need to address zero-dose girls through improved catch-up initiatives. Country representatives, including Myanmar, Malaysia, and the Philippines, shared updates on data […]

CHIC HPV vaccination in Southeast Asia and West Pacific Region – Symposium Highlights

The CHIC Symposium on HPV for Southeast Asia and the Pacific gathered 95 delegates from 17 countries in Manila to exchange strategies, challenges, and successes in vaccination programs. Discussions emphasized cultural understanding, political advocacy, and the shift toward single-dose regimens to improve coverage and sustainability. Delegates highlighted collaborative approaches for securing vaccine supply chains, addressing […]

>